Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114815) titled 'A clinical study on the safety and efficacy of anesthesia with target-controlled infusion of remimazolam or propofol in endobronchial ultrasound diagnosis and treatment' on Dec. 17, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Affiliated Hospital of Jiangsu University
Condition:
Lesions of the lungs, trachea, and mediastinum
Intervention:
Experimental group:Remimazolam + Alfentanil
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 2026-01-01
Target Sample Size: Experimental group:55;Control group:55;
Countries of Recruitment:
China
To know mor...